-
Loading metrics
HER1-Targeted 86Y-Panitumumab Possesses Superior Targeting Characteristics than 86Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
- Tapan K. Nayak,
- Kayhan Garmestani,
- Diane E. Milenic,
- Kwamena E. Baidoo,
- Martin W. Brechbiel
x
- Published: March 25, 2011
- https://doi.org/10.1371/journal.pone.0018198